Physician profile
Andrew Ernest Hack
NPI 1770927212
$4,233.97
in general payments reported to CMS, 2019-2025
19 companies · $543 in 2025
The $543 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $436 · 2020: $297 · 2021: $47.34 · 2022: $495 · 2023: $95.82 · 2024: $2,320 · 2025: $543.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,941 · Travel and Lodging: $955 · Education: $61.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,941.24 |
| Travel and Lodging | $955.44 |
| Education | $61.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,047.57 | 2022-2025 | Lensx, Clareon, Rocklatan |
| Mallinckrodt Hospital Products INC. | $396.88 | 2020-2025 | Acthar |
| Johnson & Johnson Surgical Vision, INC. | $351.09 | 2019-2024 | Tecnis Simplicity, Veritas Vision System |
| New World Medical,INC. | $307.69 | 2019-2024 | Kahook Dual Blade, Ahmed Glaucoma Valve, Streamline |
| Mallinckrodt Enterprises LLC | $189.47 | 2019 | |
| Abbvie INC. | $132.36 | 2024-2025 | |
| Aerie Pharmaceuticals, INC. | $124.80 | 2020 | |
| Sun Pharmaceutical Industries INC. | $122.21 | 2019 | |
| Rxsight INC | $110.69 | 2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Glaxosmithkline, LLC. | $103.36 | 2022 | |
| Dompe US, INC. | $72.32 | 2021-2024 | Oxervate |
| Allergan, INC. | $65.76 | 2020-2022 | |
| Oyster Point Pharma, INC. | $61.70 | 2025 | |
| Biotissue Holdings INC. | $53.05 | 2022-2025 | |
| Ocular Therapeutix, INC. | $27.89 | 2019-2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $19.13 | 2019 | |
| Bausch & Lomb Americas INC. | $18.75 | 2025 | Vyzulta |
| Harrow Eye, LLC | $16.33 | 2024 | |
| Shire North American Group INC | $12.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Hack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.